A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation.

BACKGROUND: The mammalian DNA-damage response (DDR) has evolved to protect genome stability and maximize cell survival following DNA-damage. One of the key regulators of the DDR is p53, itself tightly regulated by MDM2. Following double-strand DNA breaks (DSBs), mediators including ATM are recruited to the site of DNA-damage. Subsequent phosphorylation of p53 by ATM and ATM-induced CHK2 results in p53 stabilization, ultimately intensifying transcription of p53-responsive genes involved in DNA repair, cell-cycle checkpoint control and apoptosis. METHODS: In the current study, we investigated the stabilization and activation of p53 and associated DDR proteins in response to treatment of human colorectal cancer cells (HCT116p53+/+) with the MDM2 antagonist, Nutlin-3. RESULTS: Using immunoblotting, Nutlin-3 was observed to stabilize p53, and activate p53 target proteins. Unexpectedly, Nutlin-3 also mediated phosphorylation of p53 at key DNA-damage-specific serine residues (Ser15, 20 and 37). Furthermore, Nutlin-3 induced activation of CHK2 and ATM - proteins required for DNA-damage-dependent phosphorylation and activation of p53, and the phosphorylation of BRCA1 and H2AX - proteins known to be activated specifically in response to DNA damage. Indeed, using immunofluorescent labeling, Nutlin-3 was seen to induce formation of γH2AX foci, an early hallmark of the DDR. Moreover, Nutlin-3 induced phosphorylation of key DDR proteins, initiated cell cycle arrest and led to formation of γH2AX foci in cells lacking p53, whilst γH2AX foci were also noted in MDM2-deficient cells. CONCLUSION: To our knowledge, this is the first solid evidence showing a secondary role for Nutlin-3 as a DDR triggering agent, independent of p53 status, and unrelated to its role as an MDM2 antagonist

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Automated quantification with sub-micrometer scale precision in volumetric multicolor multiphoton microscopy images

Recent multicolor multiphoton microscopy schemes are opening the way to high quality fluorescence color imaging at near-micrometric resolution over virtually unlimited volumes of brain tissue. However, unavoidable artifacts related to depth, chromatic aberration or anisotropic resolution affect the resulting images and can bias measurements and quantifications. Here, we prove the possibility of performing precise automated quantitative measurements on such tridimensional multicolor images, taking as a model fluorescently labeled axons belonging to an auditory tract in the mouse brainstem. We present an analysis pipeline to compute the diameter of these axons based on the calculation of distance in HSV color space, its binarization using a random walker algorithm and skeleton extraction by distance transform. We measure a biologically meaningful difference of about 500 nm before and after the axons enter their target nucleus where they form synaptic connections, proving the robustness of our pipeline with respect to the aforementioned limitations. This demonstrates the ability of sub-micrometric measurements across tissue depths of 0.5 mm with multicolor multiphoton microscopy. © 2019 IEEE

Neural Cell Segmentation in Large-Scale 3D Color Fluorescence Microscopy Images for Developemental Neuroscience

International audienceThe cells composing brain tissue, neurons, and glia, form extraordinarily complex networks that support cognitive functions. Understanding the organization and development of these networks requires quantitative data resolved at the single cell level. To this aim, we apply novel large-scale 3D multicolor microscopy methodologies in combination with “Brainbow”, a transgenic approach enabling to label neural cells with diverse combinations of spectrally distinct fluorescent proteins. In this paper, we present a pipeline based on Convolutional Neural Network (CNN) to detect and segment individual astrocytes, the main type of glial cells of the brain, and map the domains occupied by their fine processes. This bioimage analysis approach successfully handles the challenging variety of astrocyte shape, color, size and their overlap with background elements. Our method shows significant improvement compared with classical techniques, opening the way to varied biological inquiries

Living cells dry mass measurements using Quantitative Phase Imaging with Quadri Wave Lateral Shearing Interferometry. An accuracy and sensitivity discussion

International audienc

Dry mass and cell cycle follow-up from quantitative phase imaging

International audienc

Laser femtoseconde entierement fibre emettant a 1650 nm et application a la microscopie tri-photonique

National audienc

All-fiber femtosecond laser providing 9 nJ, 50 MHz pulses at 1650 nm for three-photon microscopy

WOS:000402561100001International audienceThe spectral window lying between 1.6 and 1.7 mu m is interesting for in-depth multiphoton microscopy of intact tissues due to reduced scattering and absorption in this wavelength range. However, wide adoption of this excitation range will rely on the availability of robust and cost-effective high peak power pulsed lasers operating at these wavelengths. In this communication, we report on a monolithically integrated high repetition rate (50 MHz) all-fiber femtosecond laser based on a soliton self-frequency shift providing 9 nJ, 75 fs pulses at 1650 nm. We illustrate its potential for biological microscopy by recording three-photon-excited fluorescence and third-harmonic generation images of mouse nervous tissue and developing Drosophila embryos labeled with a red fluorescent protein

Three-Photon Microscopy with a Monolithic All-Fiber Format Laser Emitting at 1650 nm

WOS:000389537400157International audienceno abstrac